Europe Oncology Biosimilars Market Report 2016

Publisher Name :
Date: 21-Sep-2016
No. of pages: 123
Inquire Before Buying

Notes:

Sales, means the sales volume of Oncology Biosimilars

Revenue, means the sales value of Oncology Biosimilars

This report studies sales (consumption) of Oncology Biosimilars in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Covidien llc (Medtronic)

- Johnson & Johnson MEDICAL

- Bolton Surgical

- Platts & Nisbett

- Frankenman International

- Changzhou Waston

- Jiangsu Qianjing Medical

- Changzhou Anker Medical

- Changzhou Tongchuang Medical

- Jiangsu Reable Medical

- Changzhou Resource Medical

- Jiangsu Kangjin Medical

- Pfizer

- Wockhardt

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Oncology Biosimilars in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on sales, market share and growth rate of Oncology Biosimilars in each application, can be divided into

- Application 1

- Application 2

- Application 3

Europe Oncology Biosimilars Market Report 2016

Table of Contents
Europe Oncology Biosimilars Market Report 2016
1 Oncology Biosimilars Overview
1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Classification of Oncology Biosimilars
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Oncology Biosimilars
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Oncology Biosimilars Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Oncology Biosimilars (2011-2021)
1.5.1 Europe Oncology Biosimilars Sales and Growth Rate (2011-2021)
1.5.2 Europe Oncology Biosimilars Revenue and Growth Rate (2011-2021)
2 Europe Oncology Biosimilars by Manufacturers, Type and Application
2.1 Europe Oncology Biosimilars Market Competition by Manufacturers
2.1.1 Europe Oncology Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Oncology Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Oncology Biosimilars (Volume and Value) by Type
2.2.1 Europe Oncology Biosimilars Sales and Market Share by Type (2011-2016)
2.2.2 Europe Oncology Biosimilars Revenue and Market Share by Type (2011-2016)
2.3 Europe Oncology Biosimilars (Volume and Value) by Countries
2.3.1 Europe Oncology Biosimilars Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Oncology Biosimilars Revenue and Market Share by Countries (2011-2016)
2.4 Europe Oncology Biosimilars (Volume) by Application
3 Germany Oncology Biosimilars (Volume, Value and Sales Price)
3.1 Germany Oncology Biosimilars Sales and Value (2011-2016)
3.1.1 Germany Oncology Biosimilars Sales and Growth Rate (2011-2016)
3.1.2 Germany Oncology Biosimilars Revenue and Growth Rate (2011-2016)
3.1.3 Germany Oncology Biosimilars Sales Price Trend (2011-2016)
3.2 Germany Oncology Biosimilars Sales and Market Share by Manufacturers
3.3 Germany Oncology Biosimilars Sales and Market Share by Type
3.4 Germany Oncology Biosimilars Sales and Market Share by Application
4 France Oncology Biosimilars (Volume, Value and Sales Price)
4.1 France Oncology Biosimilars Sales and Value (2011-2016)
4.1.1 France Oncology Biosimilars Sales and Growth Rate (2011-2016)
4.1.2 France Oncology Biosimilars Revenue and Growth Rate (2011-2016)
4.1.4 France Oncology Biosimilars Sales Price Trend (2011-2016)
4.2 France Oncology Biosimilars Sales and Market Share by Manufacturers
4.3 France Oncology Biosimilars Sales and Market Share by Type
4.4 France Oncology Biosimilars Sales and Market Share by Application
5 UK Oncology Biosimilars (Volume, Value and Sales Price)
5.1 UK Oncology Biosimilars Sales and Value (2011-2016)
5.1.1 UK Oncology Biosimilars Sales and Growth Rate (2011-2016)
5.1.2 UK Oncology Biosimilars Revenue and Growth Rate (2011-2016)
5.1.5 UK Oncology Biosimilars Sales Price Trend (2011-2016)
5.2 UK Oncology Biosimilars Sales and Market Share by Manufacturers
5.3 UK Oncology Biosimilars Sales and Market Share by Type
5.4 UK Oncology Biosimilars Sales and Market Share by Application
6 Russia Oncology Biosimilars (Volume, Value and Sales Price)
6.1 Russia Oncology Biosimilars Sales and Value (2011-2016)
6.1.1 Russia Oncology Biosimilars Sales and Growth Rate (2011-2016)
6.1.2 Russia Oncology Biosimilars Revenue and Growth Rate (2011-2016)
6.1.6 Russia Oncology Biosimilars Sales Price Trend (2011-2016)
6.2 Russia Oncology Biosimilars Sales and Market Share by Manufacturers
6.3 Russia Oncology Biosimilars Sales and Market Share by Type
6.4 Russia Oncology Biosimilars Sales and Market Share by Application
7 Italy Oncology Biosimilars (Volume, Value and Sales Price)
7.1 Italy Oncology Biosimilars Sales and Value (2011-2016)
7.1.1 Italy Oncology Biosimilars Sales and Growth Rate (2011-2016)
7.1.2 Italy Oncology Biosimilars Revenue and Growth Rate (2011-2016)
7.1.7 Italy Oncology Biosimilars Sales Price Trend (2011-2016)
7.2 Italy Oncology Biosimilars Sales and Market Share by Manufacturers
7.3 Italy Oncology Biosimilars Sales and Market Share by Type
7.4 Italy Oncology Biosimilars Sales and Market Share by Application
8 Spain Oncology Biosimilars (Volume, Value and Sales Price)
8.1 Spain Oncology Biosimilars Sales and Value (2011-2016)
8.1.1 Spain Oncology Biosimilars Sales and Growth Rate (2011-2016)
8.1.2 Spain Oncology Biosimilars Revenue and Growth Rate (2011-2016)
8.1.8 Spain Oncology Biosimilars Sales Price Trend (2011-2016)
8.2 Spain Oncology Biosimilars Sales and Market Share by Manufacturers
8.3 Spain Oncology Biosimilars Sales and Market Share by Type
8.4 Spain Oncology Biosimilars Sales and Market Share by Application
9 Benelux Oncology Biosimilars (Volume, Value and Sales Price)
9.1 Benelux Oncology Biosimilars Sales and Value (2011-2016)
9.1.1 Benelux Oncology Biosimilars Sales and Growth Rate (2011-2016)
9.1.2 Benelux Oncology Biosimilars Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Oncology Biosimilars Sales Price Trend (2011-2016)
9.2 Benelux Oncology Biosimilars Sales and Market Share by Manufacturers
9.3 Benelux Oncology Biosimilars Sales and Market Share by Type
9.4 Benelux Oncology Biosimilars Sales and Market Share by Application
10 Europe Oncology Biosimilars Manufacturers Analysis
10.1 Covidien llc (Medtronic)
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Oncology Biosimilars Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Covidien llc (Medtronic) Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Johnson & Johnson MEDICAL
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Oncology Biosimilars Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Johnson & Johnson MEDICAL Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Bolton Surgical
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Oncology Biosimilars Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Bolton Surgical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Platts & Nisbett
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Oncology Biosimilars Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Platts & Nisbett Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Frankenman International
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Oncology Biosimilars Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Frankenman International Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Changzhou Waston
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Oncology Biosimilars Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Changzhou Waston Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Jiangsu Qianjing Medical
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Oncology Biosimilars Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Jiangsu Qianjing Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Changzhou Anker Medical
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Oncology Biosimilars Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Changzhou Anker Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Changzhou Tongchuang Medical
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Oncology Biosimilars Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Changzhou Tongchuang Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Jiangsu Reable Medical
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Oncology Biosimilars Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Jiangsu Reable Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 Changzhou Resource Medical
10.12 Jiangsu Kangjin Medical
10.13 Pfizer
10.14 Wockhardt
11 Oncology Biosimilars Manufacturing Cost Analysis
11.1 Oncology Biosimilars Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Oncology Biosimilars
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Oncology Biosimilars Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Oncology Biosimilars Market Forecast (2016-2021)
14.1 Germany Oncology Biosimilars Sales Forecast (2016-2021)
14.2 France Oncology Biosimilars Sales Forecast (2016-2021)
14.3 UK Oncology Biosimilars Sales Forecast (2016-2021)
14.4 Russia Oncology Biosimilars Sales Forecast (2016-2021)
14.5 Italy Oncology Biosimilars Sales Forecast (2016-2021)
14.6 Spain Oncology Biosimilars Sales Forecast (2016-2021)
14.7 Benelux Oncology Biosimilars Sales Forecast (2016-2021)
14.8 Europe Oncology Biosimilars Sales Forecast by Type (2016-2021)
14.9 Europe Oncology Biosimilars Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Oncology Biosimilars
Table Classification of Oncology Biosimilars
Figure Europe Sales Market Share of Oncology Biosimilars by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Oncology Biosimilars
Figure Europe Sales Market Share of Oncology Biosimilars by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure France Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure UK Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Russia Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Italy Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Spain Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Benelux Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Europe Oncology Biosimilars Sales and Growth Rate (2011-2021)
Figure Europe Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Table Europe Oncology Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table Europe Oncology Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Oncology Biosimilars Sales Share by Manufacturers
Figure 2016 Oncology Biosimilars Sales Share by Manufacturers
Table Europe Oncology Biosimilars Revenue by Manufacturers (2015 and 2016)
Table Europe Oncology Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Oncology Biosimilars Revenue Share by Manufacturers
Table 2016 Europe Oncology Biosimilars Revenue Share by Manufacturers
Table Europe Oncology Biosimilars Sales and Market Share by Type (2011-2016)
Table Europe Oncology Biosimilars Sales Share by Type (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Type (2011-2016)
Figure Europe Oncology Biosimilars Sales Growth Rate by Type (2011-2016)
Table Europe Oncology Biosimilars Revenue and Market Share by Type (2011-2016)
Table Europe Oncology Biosimilars Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Oncology Biosimilars by Type (2011-2016)
Figure Europe Oncology Biosimilars Revenue Growth Rate by Type (2011-2016)
Table Europe Oncology Biosimilars Sales and Market Share by Countries (2011-2016)
Table Europe Oncology Biosimilars Sales Share by Countries (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Countries (2011-2016)
Table Europe Oncology Biosimilars Revenue and Market Share by Countries (2011-2016)
Table Europe Oncology Biosimilars Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Oncology Biosimilars by Countries (2011-2016)
Table Europe Oncology Biosimilars Sales and Market Share by Application (2011-2016)
Table Europe Oncology Biosimilars Sales Share by Application (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Application (2011-2016)
Figure Germany Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Germany Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Germany Oncology Biosimilars Sales Price Trend (2011-2016)
Table Germany Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Germany Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Germany Oncology Biosimilars Sales by Type (2015 and 2016)
Table Germany Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Germany Oncology Biosimilars Sales by Application (2015 and 2016)
Table Germany Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure France Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure France Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure France Oncology Biosimilars Sales Price Trend (2011-2016)
Table France Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table France Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table France Oncology Biosimilars Sales by Type (2015 and 2016)
Table France Oncology Biosimilars Market Share by Type (2015 and 2016)
Table France Oncology Biosimilars Sales by Application (2015 and 2016)
Table France Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure UK Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure UK Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure UK Oncology Biosimilars Sales Price Trend (2011-2016)
Table UK Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table UK Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table UK Oncology Biosimilars Sales by Type (2015 and 2016)
Table UK Oncology Biosimilars Market Share by Type (2015 and 2016)
Table UK Oncology Biosimilars Sales by Application (2015 and 2016)
Table UK Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Russia Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Russia Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Russia Oncology Biosimilars Sales Price Trend (2011-2016)
Table Russia Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Russia Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Russia Oncology Biosimilars Sales by Type (2015 and 2016)
Table Russia Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Russia Oncology Biosimilars Sales by Application (2015 and 2016)
Table Russia Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Italy Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Italy Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Italy Oncology Biosimilars Sales Price Trend (2011-2016)
Table Italy Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Italy Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Italy Oncology Biosimilars Sales by Type (2015 and 2016)
Table Italy Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Italy Oncology Biosimilars Sales by Application (2015 and 2016)
Table Italy Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Spain Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Spain Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Spain Oncology Biosimilars Sales Price Trend (2011-2016)
Table Spain Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Spain Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Spain Oncology Biosimilars Sales by Type (2015 and 2016)
Table Spain Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Spain Oncology Biosimilars Sales by Application (2015 and 2016)
Table Spain Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Benelux Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Benelux Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Benelux Oncology Biosimilars Sales Price Trend (2011-2016)
Table Benelux Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Benelux Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Benelux Oncology Biosimilars Sales by Type (2015 and 2016)
Table Benelux Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Benelux Oncology Biosimilars Sales by Application (2015 and 2016)
Table Benelux Oncology Biosimilars Market Share by Application (2015 and 2016)
Table Oncology Biosimilars Basic Information List
Table Covidien llc (Medtronic) Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Covidien llc (Medtronic) Oncology Biosimilars Sales Market Share (2011-2016)
Table Johnson & Johnson MEDICAL Basic Information List
Table Johnson & Johnson MEDICAL Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson MEDICAL Oncology Biosimilars Sales Market Share (2011-2016)
Table Bolton Surgical Basic Information List
Table Bolton Surgical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bolton Surgical Oncology Biosimilars Sales Market Share (2011-2016)
Table Platts & Nisbett Basic Information List
Table Platts & Nisbett Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Platts & Nisbett Oncology Biosimilars Sales Market Share (2011-2016)
Table Frankenman International Basic Information List
Table Frankenman International Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Frankenman International Oncology Biosimilars Sales Market Share (2011-2016)
Table Changzhou Waston Basic Information List
Table Changzhou Waston Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Waston Oncology Biosimilars Sales Market Share (2011-2016)
Table Jiangsu Qianjing Medical Basic Information List
Table Jiangsu Qianjing Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Qianjing Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Changzhou Anker Medical Basic Information List
Table Changzhou Anker Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Anker Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Changzhou Tongchuang Medical Basic Information List
Table Changzhou Tongchuang Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Tongchuang Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Jiangsu Reable Medical Basic Information List
Table Jiangsu Reable Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Reable Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Changzhou Resource Medical Basic Information List
Table Changzhou Resource Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Resource Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Jiangsu Kangjin Medical Basic Information List
Table Jiangsu Kangjin Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Kangjin Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Oncology Biosimilars Sales Market Share (2011-2016)
Table Wockhardt Basic Information List
Table Wockhardt Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wockhardt Oncology Biosimilars Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure Germany Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Germany Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure France Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure France Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure UK Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure UK Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Russia Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Italy Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Spain Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table Europe Oncology Biosimilars Sales Forecast by Type (2016-2021)
Table Europe Oncology Biosimilars Sales Forecast by Application (2016-2021)
  • United States Ipilimumab Market Report 2016
    Published: 07-Dec-2016        Price: US 3800 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Ipilimumab Revenue, means the sales value of Ipilimumab This report studies sales (consumption) of Ipilimumab in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Pfizer - Novartis - Bayer - Roche - Bristol-Myers Squibb - Merck & Co. - Exelixis - ... Split by product types, with sales, r......
  • United States Meningococcal Vaccines Market Report 2016
    Published: 07-Dec-2016        Price: US 3800 Onwards        Pages: 100
    Notes: Sales, means the sales volume of Meningococcal Vaccines Revenue, means the sales value of Meningococcal Vaccines This report studies sales (consumption) of Meningococcal Vaccines in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - GlaxoSmithKline - Sanofi Pasteur - Merck - Decartis - Pfizer - bioCSL (Seqirus) - Protein Sciences - .........
  • United States Sodium Benzyl Ketone Market Report 2016
    Published: 07-Dec-2016        Price: US 3800 Onwards        Pages: 104
    Notes: Sales, means the sales volume of Sodium Benzyl Ketone Revenue, means the sales value of Sodium Benzyl Ketone This report studies sales (consumption) of Sodium Benzyl Ketone in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Boehringer Ingelheim - Bayer - Janssen (Johnson & Johnson) - Bristol-Myers Squibb - Pfizer - Daiichi-Sankyo - Portola......
  • Global Allergy Immunotherapies Market Research Report 2016
    Published: 07-Dec-2016        Price: US 2900 Onwards        Pages: 113
    Notes: Production, means the output of Allergy Immunotherapies Revenue, means the sales value of Allergy Immunotherapies This report studies Allergy Immunotherapies in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Adamis Pharmaceuticals - Aimmune Therapeutics - Anergis......
  • Europe Pembrolizumab Market Report 2016
    Published: 07-Dec-2016        Price: US 3900 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Pembrolizumab Revenue, means the sales value of Pembrolizumab This report studies sales (consumption) of Pembrolizumab in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Merck & Co., Inc. - Novartis AG - Onxeo SA - Sumitomo Dainippon......
  • United States Allergy Medicine Market Report 2016
    Published: 07-Dec-2016        Price: US 3800 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Allergy Medicine Revenue, means the sales value of Allergy Medicine This report studies sales (consumption) of Allergy Medicine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Sanofi - Johnson & Johnson - Bayer - Matrixx Initiatives - AstraZeneca - GSK - Pfizer - Chattem Split by pr......
  • United States Human Hepatitis B Immunoglobulin Market Report 2016
    Published: 07-Dec-2016        Price: US 3800 Onwards        Pages: 103
    Notes: Sales, means the sales volume of Human Hepatitis B Immunoglobulin Revenue, means the sales value of Human Hepatitis B Immunoglobulin This report studies sales (consumption) of Human Hepatitis B Immunoglobulin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Baxter - CSL - Bayer - Grifols - Octapharma - Shanghai RAAS - ... ......
  • United States Human Thrombin Market Report 2016
    Published: 07-Dec-2016        Price: US 3800 Onwards        Pages: 104
    Notes: Sales, means the sales volume of Human Thrombin Revenue, means the sales value of Human Thrombin This report studies sales (consumption) of Human Thrombin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Baxter - CSL - Bayer - Grifols - Octapharma - Shanghai RAAS - Hualan Biological - Shanghai Institute of Biological ......
  • Global Single Nucleotide Polymorphism (SNP) Genotyping Market Research Report 2016
    Published: 07-Dec-2016        Price: US 2900 Onwards        Pages: 120
    Notes: Production, means the output of Single Nucleotide Polymorphism (SNP) Genotyping Revenue, means the sales value of Single Nucleotide Polymorphism (SNP) Genotyping This report studies Single Nucleotide Polymorphism (SNP) Genotyping in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Il......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs